Found: 18
Select item for more details and to access through your institution.
New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies.
- Published in:
- Experimental Hematology & Oncology, 2016, v. 5, p. 1, doi. 10.1186/s40164-016-0036-3
- By:
- Publication type:
- Article
Echinococcus multilocularis vesicular fluid induces the expression of immune checkpoint proteins in vitro.
- Published in:
- Parasite Immunology, 2020, v. 42, n. 6, p. 1, doi. 10.1111/pim.12711
- By:
- Publication type:
- Article
Immunogenicity Evaluation of a Rationally Designed Polytope Construct Encoding HLA-A*0201 Restricted Epitopes Derived from Leishmania major Related Proteins in HLA-A2/DR1 Transgenic Mice: Steps toward Polytope Vaccine.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0108848
- By:
- Publication type:
- Article
Double Positive CD4CD8 αβ T Cells: A New Tumor- Reactive Population in Human Melanomas.
- Published in:
- PLoS ONE, 2010, v. 5, n. 1, p. 1, doi. 10.1371/journal.pone.0008437
- By:
- Publication type:
- Article
An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 3, p. 431, doi. 10.1007/s00262-009-0762-z
- By:
- Publication type:
- Article
A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 2, p. 271, doi. 10.1007/s00262-008-0551-0
- By:
- Publication type:
- Article
A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 745, doi. 10.1007/s00262-007-0436-7
- By:
- Publication type:
- Article
Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 4, p. 515, doi. 10.1007/s00262-006-0204-0
- By:
- Publication type:
- Article
Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells.
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133168
- By:
- Publication type:
- Article
Harnessing Antitumor CD4 + T Cells for Cancer Immunotherapy.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 260, doi. 10.3390/cancers14010260
- By:
- Publication type:
- Article
Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Impact of STAT3 Phosphorylation on the Clinical Effectiveness of Anti-EGFR–Based Therapy in Patients With Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 1, p. 28, doi. 10.1016/j.clcc.2012.09.002
- By:
- Publication type:
- Article
Validation of a method evaluating T cell metabolic potential in compliance with ICH Q2 (R1).
- Published in:
- 2021
- By:
- Publication type:
- journal article
CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 11, p. 3112, doi. 10.1002/ijc.32620
- By:
- Publication type:
- Article
Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological score.
- Published in:
- International Journal of Cancer, 2016, v. 139, n. 10, p. 2325, doi. 10.1002/ijc.30367
- By:
- Publication type:
- Article
CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes.
- Published in:
- International Journal of Cancer, 2015, v. 137, n. 1, p. 116, doi. 10.1002/ijc.29366
- By:
- Publication type:
- Article
Characterization of atypical T cells generated during ex vivo expansion process for T cell-based adoptive immunotherapy.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1202017
- By:
- Publication type:
- Article
Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy.
- Published in:
- European Journal of Immunology, 2010, v. 40, n. 6, p. 1786, doi. 10.1002/eji.200940132
- By:
- Publication type:
- Article